merged_africa-snakebite-treatment-access.txt
<question_number>1</question_number>
<answer>Puff adder venom destroys blood-clotting factors, causing bleeding in the brain, eyes, and mouth, which led to irreversible tissue damage despite antivenom administration.</answer>

<question_number>2</question_number>
<answer>Indian antivenoms target kraits, while Kenyan puff adders produce different venom compositions, rendering Indian antivenoms ineffective due to regional venom variation.</answer>

<question_number>3</question_number>
<answer>N/A</answer>

<question_number>4</question_number>
<answer>Spitting cobra venom causes ocular injuries mimicking non-venomous trauma, leading to misdiagnosis by traditional healers who lack tools to identify venomous causes.</answer>

<question_number>5</question_number>
<answer>Rainy seasons flood snake habitats, increasing human encounters, while dry seasons drive snakes toward farms and homes, peaking risks for farmers and rural residents.</answer>

<question_number>6</question_number>
<answer>Black mambas have short, erect fangs, rapid-acting neurotoxins, and fast movement, enabling swift envenomation compared to puff adders' slower-acting hemotoxic venom.</answer>

<question_number>7</question_number>
<answer>Antivenom's need for cold storage and sterile conditions conflicts with limited infrastructure, delaying treatment past the critical six-hour window, worsening outcomes for pregnant victims.</answer>

<question_number>8</question_number>
<answer>Tourniquets exacerbate tissue damage by cutting off blood flow, while traditional treatments delay hospital care, worsening outcomes despite intentions to halt venom spread.</answer>